Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic agent for meibomian dysfunction

Therapeutic agent for meibomian dysfunction

US Patent 11612590 · Granted Mar 28, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for changing condition of eyelid of hairless animal2025
Method for changing condition of eyelid of hairless animal2025
Agent containing 4-phenylbutyrate, for preventing or treating presbyopia2025
Therapeutic agent for meibomian dysfunction2024
Therapeutic agent for meibomian dysfunction2024
Therapeutic agent for meibomian dysfunction2024
Ursodeoxycholic acid-containing agent for treating or preventing presbyopia2022
[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compou2019
[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compou2019
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compou2019
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compou2019
Method for changing condition of an eyelid for evaluation of an eyelid disease i2018